Skip to main content

Splenic Lymphomas

  • Chapter
  • First Online:
PET/CT in Lymphomas

Abstract

Spleen is involved in approximately one third of patients with non-Hodgkin lymphoma (NHL), usually secondarily, either at presentation or at the time of disease progression. On the contrary, primary splenic lymphoma is rare, comprising only 1 % of all lymphomas, although its incidence is probably underestimated. The definition of primary splenic lymphoma is controversial. Herein, we adopt a less restrictive definition of splenic lymphomas, encompassing cases presenting with splenic involvement and in which the disease may also extend to the bone marrow, blood, and liver without prominent lymphadenopathy. Splenic lymphomas include mainly the following categories: splenic marginal zone lymphoma (SMZL), hairy cell leukemia (HCL), and the provisional entities: HCL variant (HCLv), splenic diffuse red pulp small B-cell lymphoma (SDRPL), primary splenic diffuse large B-cell lymphoma (DLBCL), and Τ-γδ hepatosplenic lymphoma [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Isaacson PG, Piris MA, Berger F et al (2008) Splenic B-cell marginal zone lymphoma. In: World Health Organization Classification of Tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 185–187

    Google Scholar 

  2. Ahmann DL, Kiely JM, Harrison EG Jr et al (1966) Malignant lymphoma of the spleen. A review of 49 cases in which the diagnosis was made at splenectomy. Cancer 19:461–469

    Article  CAS  PubMed  Google Scholar 

  3. Karunanithi S, Sharma AP, Shambo Guha R et al (2014) Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma. Clin N Med 39:772–778

    Article  Google Scholar 

  4. Liu Y (2009) Clinical significance of diffusely increased splenic uptake on FDG-PET. Nucl Med Commun 30:763–769

    Article  PubMed  Google Scholar 

  5. Matutes E, Oscier D, Montalban C et al (2008) Splenic marginal-zone lymphoma proposals for a revision of diagnosis, staging and therapeutic criteria. Leukemia 22:487–495

    Article  CAS  PubMed  Google Scholar 

  6. Kalpadakis C, Pangalis GA, Angelopoulou MK et al (2013) Treatment of splenic marginal zone lymphoma with rituximab: progress report and comparison with splenectomy. Oncologist 18:190–197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yiakoumis X, Moschogiannis M, Vassilakopoulos T et al (2011) FDG PET CT scan role on diagnosis and initial staging of lymphoproliferative diseases. Haematologica 96:574 (Abstract)

    Article  Google Scholar 

  8. Subhawong AP, Subhawong TK, Ali SZ (2012) Hairy cell leukemia presenting as a peripancreatic mass: cytomorphology and radiographic correlates. Acta Cytol 56:463–466

    Article  CAS  PubMed  Google Scholar 

  9. Rutherford SC, Andemariam B, Philips SM et al (2008) FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leuk Lymphoma 49:719–726

    Article  PubMed  Google Scholar 

  10. Mollejo M, Algara P, Mateo MS et al (2003) Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am J Surg Pathol 27:895–902

    Article  PubMed  Google Scholar 

  11. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3067

    Article  PubMed  Google Scholar 

  12. Dupuis J, Itti E, Rahmouni A, Hemery F et al (2009) Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18 fluorodeoxyglucose positron emission tomography to the International Workshop Criteria. Ann Oncol 20:503–507

    Google Scholar 

  13. Thomas A, Gingrich RD, Smith BJ et al (2010) 18-fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of “indeterminate” reports. Leuk Lymphoma 51:439–446

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Pangalis GA, Vassilakopoulos TP, Dimopoulou MN et al (2002) Chronic lymphocytic leukemia: practical aspects. Hematol Oncol 20:103–146

    Article  PubMed  Google Scholar 

  15. Bruzzi JF, Macapinlac H, Tsimberidou AM et al (2006) Detection of Richter’s transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 47:1267–1273

    PubMed  Google Scholar 

  16. Falchi L, Keating MJ, Marom EM et al (2014) Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood 123:2783–2790

    Google Scholar 

  17. Papajík T, Mysliveček M, Urbanová R et al (2014) 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation. Leuk Lymphoma 55:314–319

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christina Kalpadakis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kalpadakis, C., Pangalis, G.A., Kechagias, D.T., Yiakoumis, X., Vlachou, F.J. (2016). Splenic Lymphomas. In: Andreou, J., Kosmidis, P., Gouliamos, A. (eds) PET/CT in Lymphomas. Springer, Cham. https://doi.org/10.1007/978-3-319-27380-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27380-8_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27378-5

  • Online ISBN: 978-3-319-27380-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics